John Gallagher Sells 431 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 431 shares of the stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $25.08, for a total transaction of $10,809.48. Following the transaction, the chief operating officer owned 32,203 shares of the company’s stock, valued at approximately $807,651.24. The trade was a 1.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Stock Performance

NASDAQ TRUP traded down $1.37 during trading hours on Thursday, reaching $24.48. 294,301 shares of the company were exchanged, compared to its average volume of 415,608. The stock has a market capitalization of $1.07 billion, a P/E ratio of 41.49 and a beta of 1.39. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.00. The business’s 50 day simple moving average is $24.22 and its 200-day simple moving average is $26.57.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm had revenue of $384.05 million during the quarter, compared to the consensus estimate of $379.77 million. During the same period in the prior year, the firm earned ($0.03) EPS. The company’s revenue was up 12.3% compared to the same quarter last year. On average, equities research analysts expect that Trupanion, Inc. will post 0.55 earnings per share for the current year.

Analysts Set New Price Targets

TRUP has been the subject of several research reports. Cantor Fitzgerald reduced their price objective on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Finally, Stifel Nicolaus set a $28.00 price objective on shares of Trupanion in a report on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $41.60.

Institutional Investors Weigh In On Trupanion

Hedge funds and other institutional investors have recently bought and sold shares of the business. Kelleher Financial Advisors purchased a new stake in shares of Trupanion during the third quarter worth $74,000. Kemnay Advisory Services Inc. purchased a new position in shares of Trupanion in the fourth quarter valued at $64,000. Parallel Advisors LLC raised its stake in shares of Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. Advisory Services Network LLC bought a new stake in shares of Trupanion during the 3rd quarter valued at $160,000. Finally, Tidal Investments LLC purchased a new stake in Trupanion during the 2nd quarter worth about $212,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.